5115 ULMERTON ROAD, CLEARWATER, FL
Apyx Medical Corporation Approves 2026 Share Incentive Plan
Reports Second Quarter 2026 Financial Results
Apyx Medical Corporation Reconstitutes Board Committees
Apyx Medical Corporation Appoints Stavros Vizirgianakis as Executive Chairman
New Study Shows Significant Improvement in Cellulite and Skin Laxity with Advanced Minimally Invasive Treatment Utilizing Avéli® and Renuvion®
Announces Retrospective Clinical Publication Evaluating Clinical Benefit of Renuvion® Used In Combination With Liposuction
Other Events
Reports First Quarter 2026 Financial Results
Q2
Q1
FY 2025
Q3
FY 2024
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Specialized Disclosure Report
Submission Upload
Correspondence